Thank you, Madam Chairperson.
Thanks to all of you.
I want to start by dealing with the issue of reporting of adverse reactions, since it has been a dominant theme here at this committee.
Bill C-51 says that a health care institution “shall” provide the minister with information about adverse reactions. My first question is that in the past, when we've tried to suggest a role for the federal government in coordinating information and strategies across the country, we have been told that the federal government can't do that because of jurisdictional issues. Why or how is this possible now? Has there been a legal interpretation of this? On what basis is this going to be possible?